Literature DB >> 11157920

Antibiotic activity against genotypically distinct and indistinguishable Clostridium difficile isolates.

J Freeman, M H Wilcox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11157920     DOI： 10.1093/jac/47.2.244

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.

Authors:  Anne-Marie Bourgault; François Lamothe; Vivian G Loo; Louise Poirier
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

2.  Molecular epidemiology of endemic Clostridium difficile infection and the significance of subtypes of the United Kingdom epidemic strain (PCR ribotype 1).

Authors:  Warren N Fawley; Peter Parnell; Paul Verity; Jane Freeman; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.

Authors:  Adrián Camacho-Ortiz; Eva María Gutiérrez-Delgado; Jose F Garcia-Mazcorro; Soraya Mendoza-Olazarán; Adrián Martínez-Meléndez; Laura Palau-Davila; Simon D Baines; Héctor Maldonado-Garza; Elvira Garza-González
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

4.  Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin.

Authors:  Sandra Maaß; Andreas Otto; Dirk Albrecht; Katharina Riedel; Anke Trautwein-Schult; Dörte Becher
Journal:  Cells       Date:  2018-11-15       Impact factor: 6.600

Review 5.  Role of cephalosporins in the era of Clostridium difficile infection.

Authors:  Mark H Wilcox; James D Chalmers; Carl E Nord; Jane Freeman; Emilio Bouza
Journal:  J Antimicrob Chemother       Date:  2016-09-22       Impact factor: 5.790
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.